Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Clinical trial NCT01132313 · COMPLETED

Trial details

NCT number: NCT01132313
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2010-05-01
Primary completion: 2014-10-01
Enrollment: 488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.